Nowicki Roman, Trzeciak Magdalena, Wilkowska Aleksandra, Sokołowska-Wojdyło Małgorzata, Ługowska-Umer Hanna, Barańska-Rybak Wioletta, Kaczmarski Maciej, Kowalewski Cezary, Kruszewski Jerzy, Maj Joanna, Silny Wojciech, Śpiewak Radosław, Petranyuk Andriy
Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland. Head of the Department: Prof. Roman Nowicki MD, PhD.
School of Medical Science of Bialystok, Bialystok, Poland. Head of the Department: Prof. Zbigniew Puchalski MD, PhD.
Postepy Dermatol Alergol. 2015 Aug;32(4):239-49. doi: 10.5114/pdia.2015.53319. Epub 2015 Aug 12.
Atopic dermatitis (AD) is a condition frequently encountered in medical practices across the country. More than 60% of children with AD are at risk to develop allergic rhinitis or asthma (the atopic march). Patients with AD have a unique predisposition to colonization or infection by Staphylococcus aureus. Treatments for AD need to rapidly control symptoms of the disease, improve quality of life and prevent exacerbations. Given the chronic and relapsing nature of the disease, therapies need to encourage good compliance and be well tolerated.
特应性皮炎(AD)是全国各地医疗实践中经常遇到的一种病症。超过60%的AD患儿有患过敏性鼻炎或哮喘(特应性进程)的风险。AD患者对金黄色葡萄球菌定植或感染具有独特的易感性。AD的治疗需要迅速控制疾病症状,提高生活质量并预防病情加重。鉴于该疾病的慢性和复发性,治疗方法需要鼓励良好的依从性且耐受性良好。